The cattle and porcine/swine reproductive diseases refers to
the diseases which are significant concern in livestock farming which impacts
cattle and porcine reproductive health. The disease includes infections such as
bovine viral diarrhea, leptospirosis, porcine reproductive and respiratory
syndrome, etc., mainly caused by bacteria, viruses and parasites, impacting
both the animal health and farm profitability.
MARKET
OVERVIEW
The market valuation of the cattle & porcine/swine reproductive diseases market was valued at approximately USD xx billion in 2023 and is projected to reach USD xx billion in 2034 exhibiting a CAGR of xx.x% during the forecast period of 2024-2034. The market is aligned with healthcare sectors, which makes it a sustainable and growing market.
GROWTH
DRIVERS
The increase in the incidence of reproductive diseases in livestock where World Organization for Animal health supports the fact that porcine reproductive and respiratory syndrome (PRRS) in pigs and Brucellosis in cattle are increasing due to several factors, driving the demand of the market. The more the incidence rises the more it fuels the market growth. The growing focus on food security and supply chain is one of the key drivers of the market where government initiatives are aimed at prioritizing health of the livestock animals in order to ensure good and stable food production.
Moreover, Food and Agriculture also put emphasis on sustainable
livestock production, essential for food security. The increase in funding from
government and international organizations to developing regions aimed at
prevention of animal disease in order to support food security drives the
market growth. The increase in funding provides financial support for the
livestock farmers drives the adoption of the market.
MARKET
SEGMENTATION:
·
By Product and Services- Products-
(Diagnostic Kits -ELISA test kits, PCR test kits, Rapid Antigen test kits and
Others, Pharmaceuticals- Vaccines, Antibiotics, Hormonal Therapy and Others,
Supplements) and Services
·
By Animal Type-
Cattle and Porcine/Swine
·
By Disease Type-
bovine viral diarrhea virus (BVDV), porcine reproductive and respiratory
syndrome (PRRS), porcine parvovirus (PPV), leptospirosis, brucellosis,
vibriosis and others
·
By End Users-
veterinary clinics and hospitals, livestock farms and production facilities and
academic and research laboratories
·
By Regions- North America,
Europe, Asia Pacific, South America, Middle East and Africa
Cattle
& Porcine/Swine Reproductive Diseases Market Segment By Product and Service
Review:
The products segment includes diagnostics such as ELISA test kits, PCR test kits, rapid antigen test kits, etc., allowing the detection of specific antigen or antibodies in cattle and swine. The pharmaceuticals segment includes vaccines, antibiotics, hormonal therapy, etc., used for preventing reproductive disease and treat secondary infections occurring due to infections in livestock. The nutritional supplements are used to improve the overall health, improving reproductive performance in cattle and swine and overcoming the deficiencies. The services segment includes the veterinary professional services, consulting, etc.
Cattle
& Porcine/Swine Reproductive Diseases Market Segment by Diseases Review:
The BVDV is a significant viral disease, causing immune suppression that effects the cattle leading to reproductive failure and birth defects in calves. The PRRS is one the significant disease in swine that causes issues like abortions and still births as well as respiratory problems in piglets. The PPV causes reproductive failures in swine which mainly leads to mummified fetuses and infertility.
The leptospirosis is a kind of bacterial
infection transmitted through contaminated soil and water effecting the cattle
and swine both, causing infertility and death in severe cases. Brucellosis is a
zoonotic bacterial disease, causing abortion and infertility coupled with
reduced milk production in cattle. Vibriosis is another bacterial infection
caused by bacteria named Vibrio fetus which effects significantly to
cattle, causing reduced conception rates and reproductive efficiency.
Cattle
& Porcine/Swine Reproductive Diseases Market Segment by End Users Review:
The veterinary clinics and hospitals are an integral part
that diagnose and treats cattle and swine reproductive issues. It provides
medical care, vaccinations, test and therapeutic services to livestock owners
and farmers. The livestock farms and production facilities are the major end
users of the market that relies on effective disease management and prevention.
The academic and research laboratories play a pivotal role by advancing the
research and development of new diagnostic techniques, vaccines and treatments.
Regional
Analysis:
North America is a significant market driven by the significant presence of key global players in this region coupled with well-established livestock industry and focus on disease management. Europe is another significant market driven by the key global players in this region coupled with well-established livestock industry and regulatory frameworks ensuring better animal health.
Asia Pacific is a rapidly growing market due to the expansion of livestock farming coupled with the rise in meat and dairy consumption. MEA is a promising market driven by the increased focus on food security. South America is another growing market driven by significant presence of livestock industry and meat exports.
Key
Challenges:
The effective vaccines are critical for managing reproductive
diseases where the development of vaccines may be complex due to viral mutation
and varying pathogen strains, moreover, the efficacy of the vaccine impacts the
disease control, hampering the market growth. The market is incident to strict
regulatory environment, where navigating the regulatory landscape makes it
challenging as it may involve a lot of time and money, hindering the market
growth.
Competitive
Landscape:
In the highly competitive cattle & porcine/swine
reproductive diseases market, companies are investing heavily in research and
development to innovate and improve their products and services. They are also
collaborating, forming strategic partnerships, or acquiring other companies to
gain access to new market segments, enhance distribution networks, and increase
market share.
Global
Key Players:
·
Zoetis Inc.
·
Merck & Co., Inc.
·
Boehringer Ingelheim International GmBH
·
Virbac
·
Elanco Animal Health Incorporated
·
Vetoquinol S.A.
·
Ceva Santé Animale
·
Idexx Laboratories
·
Thermo Fisher Scientific Inc.
·
Biochek Smart Veterinary Diagnostics
· Other Players
|
Attributes |
Details |
|
Base Year |
2023 |
|
Trend Period |
2024 – 2034 |
|
Forecast Period |
2024 – 2034 |
|
Pages |
215 |
|
By Product and Services |
Products- (Diagnostic Kits -ELISA
test kits, PCR test kits, Rapid Antigen test kits and Others,
Pharmaceuticals- Vaccines, Antibiotics, Hormonal Therapy and Others,
Supplements) and Services |
|
By Animal Type |
Cattle and
Porcine/Swine |
|
By Disease Type |
bovine viral diarrhea
virus (BVDV), porcine reproductive and respiratory syndrome (PRRS), porcine
parvovirus (PPV), leptospirosis, brucellosis, vibriosis and others |
|
By End Users |
veterinary clinics and
hospitals, livestock farms and production facilities and academic and
research laboratories |
|
By region |
North America, Europe,
Asia Pacific, the Middle East and Africa, and South America |
|
Company Profiles |
Zoetis Inc., Merck
& Co., Inc., Boehringer Ingelheim International GmBH, Virbac, Elanco
Animal Health Incorporated, Vetoquinol S.A., Ceva Santé Animale, Idexx
Laboratories, Thermo Fisher Scientific Inc., Biochek Smart Veterinary
Diagnostics, Other Players |
|
Edition |
1st edition |
|
Publication |
November 2024 |
